Dr. Reddy's Laboratories Limited
RDYFinancial Statements
Income Statement (Annual)
Amounts in millions
2025
3/31/2025
Revenue
3,906
Cost of Revenue
1,621
Gross Profit
2,285
Gross Margin
58.5%
Operating Income
862
Operating Margin
22.1%
Net Income
679
Net Margin
17.4%
EPS (Basic)
$67.85
EPS (Diluted)
$67.77
EBITDA
1,160
EBITDA Margin
29.7%
2024
3/31/2024
Revenue
3,350
Cost of Revenue
1,387
Gross Profit
1,963
Gross Margin
58.6%
Operating Income
813
Operating Margin
24.3%
Net Income
668
Net Margin
19.9%
EPS (Basic)
$66.80
EPS (Diluted)
$66.80
EBITDA
1,061
EBITDA Margin
31.7%
2023
3/31/2023
Revenue
2,951
Cost of Revenue
1,278
Gross Profit
1,672
Gross Margin
56.7%
Operating Income
686
Operating Margin
23.2%
Net Income
541
Net Margin
18.3%
EPS (Basic)
$54.29
EPS (Diluted)
$54.17
EBITDA
893
EBITDA Margin
30.3%
2022
3/31/2022
Revenue
2,573
Cost of Revenue
1,207
Gross Profit
1,366
Gross Margin
53.1%
Operating Income
354
Operating Margin
13.7%
Net Income
283
Net Margin
11.0%
EPS (Basic)
$28.42
EPS (Diluted)
$28.34
EBITDA
541
EBITDA Margin
21.0%
2021
3/31/2021
Revenue
31
Cost of Revenue
15
Gross Profit
16
Gross Margin
50.8%
Operating Income
5
Operating Margin
16.9%
Net Income
3
Net Margin
9.1%
EPS (Basic)
$20.79
EPS (Diluted)
$20.73
EBITDA
6
EBITDA Margin
20.9%